Family

Loading Family data...

• 15 United States
• 10 France
• 8 Japan
• 7 China
• 5 Korea
• 2 Other

Patent Owner(s)

Patent Owner	Address
CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE (CNRS)	3 RUE MICHEL ANGE PARIS 75016
INSERM (INSTITUT NATIONAL DE LA SANTE ET DE LA RECHERCHE MEDICALE)	101 RUE DE TOLBIAC PARIS 75013
UNIVERSITE CLAUDE BERNARD - LYON 1	69100 VILLEURBANNE
POXEL	69007 LYON
ENS - ECOLE NORMALE SUPÉRIEURE DE LYON	46 ALLEE D'ITALIE LYON 69007
EDELRIS	115 AVENUE LACASSAGNE LYON F-69003

International Classification(s)

• A61K:PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOS....

• [Classification Symbol]

• [Patents Count]

Inventor(s)

Inventor Name	Address	# of filed Patents	Total Citations
Andre, Patrice	Lyons, FR	59	221
Cravo, Daniel	Montesson, FR	33	169
Gilardone, Marine	Millery, FR	4	35
Hallakou-Bozec, Sophie	Antony, FR	19	64
Lotteau, Vincent	Lyons, FR	25	69
Patin, Amaury	Lausanne, CH	24	35
Radreau, Pauline	Lyons, FR	2	35
Roche, Didier	Ecully, FR	22	82

Cited Art Landscape

Load Citation

• No Cited Art to Display

Loading Cited Art Landscape...

Patent Citation Ranking

Forward Cite Landscape

Load Citation

• No Forward Cites to Display

Loading Forward Cite Landscape...

Maintenance Fees

Fee	Large entity fee	small entity fee	micro entity fee	due date
7.5 Year Payment	$3600.00	$1800.00	$900.00	Aug 20, 2025
11.5 Year Payment	$7400.00	$3700.00	$1850.00	Aug 20, 2029

Fee	Large entity fee	small entity fee	micro entity fee
Surcharge - 7.5 year - Late payment within 6 months	$160.00	$80.00	$40.00
Surcharge - 11.5 year - Late payment within 6 months	$160.00	$80.00	$40.00
Surcharge after expiration - Late payment is unavoidable	$700.00	$350.00	$175.00
Surcharge after expiration - Late payment is unintentional	$1,640.00	$820.00	$410.00

DATE PUBLISHED	PUBLICATION/PATENT NO.	PUBLICATION TYPE
February 20, 2018	US,9895380,B2   US9895380B2	GRANTED PATENT AS SECOND PUBLICATION
August 04, 2016	US,20160220586,A1   US20160220586A1	FIRST PUBLISHED PATENT APPLICATION

Full Text

US Patent No: 9895380

Methods and pharmaceutical compositions for the treatment of hepatitis B virus infection

---

 

Legal Events